ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

ClinicalTrials.gov ID: NCT03428217

Public ClinicalTrials.gov record NCT03428217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)

Study identification

NCT ID
NCT03428217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Calithera Biosciences, Inc
Industry
Enrollment
444 participants

Conditions and interventions

Interventions

  • CB-839 Drug
  • Cabozantinib Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 23, 2018
Primary completion
Aug 30, 2020
Completion
Jul 15, 2021
Last update posted
Mar 19, 2023

2018 – 2021

United States locations

U.S. sites
59
U.S. states
29
U.S. cities
54
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Mayo Clinic Cancer Center Phoenix Arizona 85054
The University of Arizona Cancer Center Tucson Arizona 85724
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048
Stanford Cancer Center Palo Alto California 94304
Salinas Valley Memorial Healthcare System Salinas California 93901
St. Joseph Heritage Healthcare Santa Rosa California 95403
Penrose Cancer Center, Research Department Colorado Springs Colorado 80907
Georgetown University Medical Center Washington D.C. District of Columbia 20007
Florida Cancer Specialists Fort Myers Florida 33901
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136
Florida Cancer Specialists St. Petersburg Florida 33705
H.Lee Moffitt Cancer & Research Institute (Moffitt Cancer Center) Tampa Florida 33612
Emory Winship Cancer Institute Atlanta Georgia 30322
Georgia Cancer Center at Augusta University Augusta Georgia 30912
Northwest Georgia Oncology Centers, PC Marietta Georgia 30060
St. Luke's Mountain States Tumor Institute Boise Idaho 83712
Northwestern University Chicago Illinois 60611
University of Chicago Chicago Illinois 60637
NorthShore University HealthSystem Evanston Illinois 60201
AMITA Health Cancer Institute & Outpatient Center Hinsdale Illinois 60521
Orchard Healthcare Research, Inc. Skokie Illinois 60077
Northwestern Medicine Cancer Center Warrenville Warrenville Illinois 60555
Goshen Center for Cancer Care Goshen Indiana 46526
East Jefferson General Hospital Metairie Louisiana 70006
Ochsner Clinic Foundation New Orleans Louisiana 70121
University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201
Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Dana-Farber Cancer Institute Boston Massachusetts 02215
Karmanos Cancer Institute Detroit Michigan 48201
HealthPartners Institute, Regions Cancer Care Center Saint Paul Minnesota 55101
Hattiesburg Clinic Hematology/Oncology Hattiesburg Mississippi 39401
University of Mississippi Medical Center Jackson Mississippi 39216
Mercy Hospital Joplin Missouri 64804
HCA Midwest Health Kansas City Missouri 64132
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148
San Juan Oncology Associates, PC Farmington New Mexico 87401
Roswell Park Cancer Center Buffalo New York 14263
North Shore Hematology Oncology Associates PC dba NY Cancer and Blood Specialists East Setauket New York 11733
NYU Winthrop Hospital Mineola New York 11501
Northern Westchester Hospital Mount Kisco New York 10549
Stony Brook Cancer Center Stony Brook New York 11794
Levine Cancer Institute Charlotte North Carolina 28204
Duke University Medical Center Durham North Carolina 27710
INTEGRIS Cancer Institute of Oklahoma Proton Campus Oklahoma City Oklahoma 73142
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Allegheny General Hospital Pittsburgh Pennsylvania 15212
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center Pittsburgh Pennsylvania 15232
Medical University of South Carolina Charleston South Carolina 29425
Saint Francis Hospital Cancer Center Greenville South Carolina 29607
West Cancer Center Germantown Tennessee 38138
The Sarah Cannon Research Institute Nashville Tennessee 37203
Vanderbilt University Medical Center Nashville Tennessee 37232
The Center for Cancer and Blood Disorders Fort Worth Texas 76104
The University of Texas MD Anderson Cancer Center Houston Texas 77030
University of Utah, Huntsman Cancer Institute Salt Lake City Utah 84112
Kadlec Clinic Hematology and Oncology Kennewick Washington 99336
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03428217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 19, 2023 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03428217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →